Fentanyl and its analogues in the forensic laboratory. Medical and analytical problems;Fentanyl i jego pochodne w laboratorium toksykologicznym. Problemy medyczne i analityczne

Problems of Forensic Sciences

Volumn 59, Issue , 2004, Pages 127-142

  Skulska, Agnieszka ^a   Kała, Maria ^b   Parczewski, Andrzej ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

Fentanyl and its analogues; Medical and nonmedical use; Methods of determination; Reviews

Indexed keywords

ALFENTANIL; DIAMORPHINE; FENTANYL; FENTANYL DERIVATIVE; ILLICIT DRUG; MORPHINE; NARCOTIC ANALGESIC AGENT; REMIFENTANIL; SUFENTANIL;

ANALGESIA; ANALGESIC ACTIVITY; APNEA; ARTICLE; BLOOD LEVEL; CAUSE OF DEATH; DIZZINESS; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FORENSIC MEDICINE; HUMAN; MUSCLE RIGIDITY; NAUSEA AND VOMITING; NONHUMAN; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; SOMNOLENCE; TISSUE LEVEL;

EID: 29544451810     PISSN: 12307483     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Alburges M. E., Hanson G. R., Gibb J. W. [et al.], Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogues in urine, Journal of Analytical Toxicology 1992, vol. 16, pp. 36-41.
2. Anderson D. T., Muto J. J., Duragesic® Transdermal Patch: postmortem tissue distribution of fentanyl in 25 cases, Journal of Analytical Toxicology 2000, vol. 24, pp. 627-634.
3. Baselt R. C., Disposition of toxic drugs and chemicals in man, Biomedical Publications, Foster City 2002.
4. Bender J., van den Elshout J., Selinger K. [et al.], Determination of remifentanyl in human heparinised whole blood by tandem mass spectrometry with short-column separation, Journal of Pharmaceutical and Biomedical Analysis 1999, vol. 21, pp. 559-567.
5. Bi-Yi C., Wen-Qiao J., Jie C. [et al.], Analgesic activity and selectivity of isothiocyanate derivatives of fentanyl analogs for opioid receptors, Life Sciences 1999, vol. 65, pp. 1589-1595.
6. Bjorksten A. R., Chan C., Crankshaw D. P., Determination of remifentanyl in human blood by capillary gas chromatography with nitrogen-selective detection, Journal of Chromatography B 2002, vol. 775, pp. 97-101.
7. Choi H. S., Shin H. C., Khang G. [et al.], Quantitative analysis of fentanyl in rat plasma by gas chromatography with nitrogen-phosphorus detection, Journal of Chromatography B 2001, vol. 765, pp. 63-69.
8. Dotsikas Y., Loukas L. Y., Siafaka I., Determination of umbilical cord and maternal plasma concentrations of fentanyl by using novel spectrophotometric and chemiluminescence enzyme immunoassays, Analytica Chimica Acta 2002, vol. 459, pp. 177-185.
9. Esposito F. M., Winek C. L., The synthetic drug 3-methylfentanyl: identification and quantitation of powdered samples, Journal of Forensic Sciences 1991, vol. 36, pp. 86-92.
10. Fryirsa B., Woodhouse A., Huang J. L. [et al.], Determination of subnanogram concentrations of fentanyl in plasma by gas chromatography-mass spectrometry: comparison with standard radioimmunoassay, Journal of Chromatography B 1997, vol. 688, pp. 79-85.
11. Gaillard Y., Pépin G., Use of high-performance liquid chromatography with photodiodearray UV detection for the creation of 600-compound library. Application to forensic toxicology, Journal of Chromatography A 1997, vol. 763, pp. 149-163.
12. Girón R., Abalo R., Goicoechea C. [et al.], Synthesis and opioid activity of new fentanyl analogs, Life Sciences 2002, vol. 71, pp. 1023-1034.
13. Guitton J., Désage M., Alamercery S. [et al.], Gas chromatographic-mass spectrometry and gas chromatographic-Fourier transform infrared spectroscopy assay for the simultaneous identification of fentanyl metabolites, Journal of Chromatography B 1997, vol. 59, pp. 59-70.
14. Haidar S. H., Liang Z., Selinger K. [et al.], Determination of remifentanyl, an ultra-short-acting opioid anesthetic, in rat blood by high performance liquid chromatography with ultraviolet detection, Journal of Pharmaceutical and Biomedical Analysis 1996, vol. 14, pp. 1727-1732.
15. Henderson G. L., Designer drugs: past history and future prospects, Journal of Forensic Sciences 1988, vol. 33, pp. 569-575.
16. Henderson G. L., Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases, Journal of Forensic Sciences 1991, vol. 36, pp. 422-433.
17. Henderson G. L., Harkey M. R., Jones A. D., Rapid screening of fentanyl (China White) powder samples by Solid-Phase Radioimmunoassay, Journal of Analytical Toxicology 1990, vol. 14, pp. 172-175.
18. Jagerovic N., Cano C., Elguero J. [et al.], Long-acting fentanyl analogues: synthesis and pharmacology of N-(1-Phenylpyrazolyl)-N-(1-phenylalkyl- 4-piperidyl)propan-amides, Bioorganic & Medicinal Chemistry Letters 2002, vol. 10, pp. 817-827.
19. Kabbaj M., Varin F., Simultaneous solid-phase extraction combined with liquid chromatography with ultraviolet absorbance detection for the determination of remifentanyl and its metabolite in dog plasma, Journal of Chromatography B 2003, vol. 783, pp. 103-111.
20. Karch S., Karch's pathology of drug abuse, CRC Press, New York 2002.
21. Käferstein H., Sticht G., Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl, Forensic Science International 2000, vol. 113, pp. 353-357.
22. Kingsbury D. P., Makowski G. S., Stone J. A., Quantitative analysis of fentanyl in pharmaceutical preparations by Gas Chromatography-Mass Spectrometry, Journal of Analytical Toxicology 1995, vol. 19, pp. 27-30.
23. Koch D. E., Isaza R., Carpenter J. W. [et al.], Simultaneous extraction and quantitation of fentanyl and norfentanyl from plasma with LC/MS detection, Journal of Pharmaceutical and Biomedical Analysis 2004, vol. 34, pp. 577-584.
24. Koves E. M., Use of high-performance liquid chromatography-diode array detection in forensic toxicology, Journal of Chromatography A 1995, vol. 692, pp. 103-119.
25. Kronstrand R., Druid H., Holmgren P. [et al.], A cluster of fentanyl-related deaths among drug addicts in Sweden, Forensic Science International 1997, vol. 88, pp. 185-195.
26. Kumar K., Ballantyne J. A., Baker A. B., A sensitive assay for simultaneous measurement of alfentanyl and fentanyl in plasma, Journal of Pharmaceutical and Biomedical Analysis 1996, vol. 14, pp. 667-673.
27. Martens-Lobenhoffer J., Very sensitive and specific determination of sufentanyl in human serum applying liquid chromatography-two stage mass spectrometry, Journal of Chromatography B 2002, vol. 769, pp. 227-233.
28. Martínez R., Rubio M. F., Alfaro L. J. [et al.], Confirmational analysis of analogues of fentanyl: theoretical approach. Possible influence of the anomeric effect on its biological activity, Journal of Molecular Structure (Theochem) 1995, vol. 342, pp. 141-146.
29. Mićović I. V., Ivanović M. D., Vuckovic S. M. [et al.], The synthesis and preliminary pharmacological evaluation of 4-methyl fentanyl, Bioorganic & Medicinal Chemistry Letters 2000, vol. 10, pp. 2011-2014.
30. Ohta H., Suzuki S., Ogasawara K., Studies on fentanyl and related compounds. IV. Chromatographic and spectrometric discrimination of fentanyl and its derivatives, Journal of Analytical Toxicology 1999, vol. 23, pp. 280-285.
31. Palleschi L., Lucentini L., Ferretti E. [et al.], Quantitative determination of sufentanyl in human plasma by liquid chromatography-tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis 2003, vol. 32, pp. 329-336.
32. Podlewski J. K., Chwalibogowska-Podlewska A., Leki współ zesnej terapii, Wydawnictwa Fundacji Büchnera, Warszawa 2001.
33. Portier E. J. G., de Blok K., Butter J. J. [et al.], Simultaneous determination of fentanyl and midazolam using high-performance liquid chromatography with ultraviolet detection, Journal of Chromatography B 1999, vol. 723, pp. 313-318.
34. Rossi S. S., Dyck J. B., Yaksh T. L., Simultaneous extraction of sufentanyl and midazolam from human plasma, Clinica Chimica Acta 1996, vol. 244, pp. 103-110.
35. Ruangyuttikarn W., Law M. Y., Rollins D. E. [et al.], Detection of fentanyl and its analogs by Enzyme-Linked Immunosorbent Assay, Journal of Analytical Toxicology 1990, vol. 14, pp. 160-164.
36. Selavka C. M., Mason A. P., Riker C. D. [et al.], Determination of fentanyl in hair: the case of the crooked criminalist, Journal of Forensic Sciences 1995, vol. 40, pp. 681-685.
37. Smialek J. E., Levine B., Chin L. [et al.], A fentanyl epidemic in Maryland 1992, Journal of Forensic Sciences 1994, vol. 39, pp. 159-164.
38. Soriano C., Muńoz-Guerra J., Carreras D. [et al.], Automated analysis of drugs in urine, Journal of Chromatography B 1996, vol. 687, pp. 183-187.
39. Szeitz A., Riggs K. W., Harvey-Clark C., Sensitive and selective assay for fentanyl using gas chromatography with mass selective detection, Journal of Chromatography B 1996, vol. 675, pp. 33-42.
40. Szukalski B., Narkotyki zmodyfikowane. Czȩść II. Zwia̧zki o działaniu opiatopodobnym, Problemy Kryminalistyki 2004, nr 244, s. 5-11.
41. Valter K., Arrizabalaga P., Designer drugs directory, Elsevier, New York 1998.
42. Van Nimmen N. F. J., Poels K. L. C., Veulemans H. A. F., Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanyl and alfentanyl and their major metabolites in urine of opioid exposed workers, Journal of Chromatography B 2004, vol. 804, pp. 375-387.
43. Watts V. W., Caplan Y. H., Evaluation of the Coat-A-Count 125I fentanyl RIA: comparison of 1251 RIA and GC/MS-SIM for quantification of fentanyl in case urine specimens, Journal of Analytical Toxicology 1990, vol. 14, pp. 266-272.
44. Wills S., Drugs of abuse, The Pharmaceutical Press, London 1997.
45. Winek C. L., Wahba W. W., Winek Jr. C. L. [et al.], Drug and chemical blood-level data 2001, vol. 122, pp. 107-123.
46. www.dea.gov/concern/fentanyl.html
47. www.roche.pl/lekarze/publikacje/sedacja_d/11.html